Nova Eye Medical Limited
ASX:EYE.AX
0.17 (AUD) • At close October 30, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Nova Eye Medical Limited |
Symbool | EYE.AX |
Munteenheid | AUD |
Prijs | 0.175 |
Beurswaarde | 40,085,675 |
Dividendpercentage | 0% |
52-weken bereik | 0.115 - 0.325 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Mr. Victor Previn B.E., B.Eng |
Website | https://nova-eye.com |
An error occurred while fetching data.
Over Nova Eye Medical Limited
Nova Eye Medical Limited designs, develops, distributes, markets, sells, and services surgical devices for the treatment of glaucoma. The company offers iTrack, a surgical system for the reduction in intraocular pressure (IOP) in adult patients with open-angle glaucoma; iTrack Advance, a natural ocular drainage system; Molteno3, a glaucoma drainage device
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (AUD)
Cijfers zijn in miljoenen (AUD)